Prostate Cancer Initiative

Prostate cancer is a disease that begins in the prostate gland, a small, walnut-shaped gland located just below the bladder in men. This gland produces seminal fluid, which nourishes and transports sperm. Prostate cancer occurs when cells in the prostate gland begin to grow uncontrollably, forming a tumor.  

Often, in its early stages, prostate cancer may not cause any noticeable symptoms. This is why regular screening, especially for men over a certain age or those with risk factors, is so important. As the cancer progresses, some men may experience symptoms such as frequent urination, especially at night, difficulty starting or stopping urination, a weak or interrupted urine stream, pain or burning during urination, blood in the urine or semen, and erectile dysfunction. However, these symptoms can also be caused by other less serious conditions, like an enlarged prostate (benign prostatic hyperplasia or BPH).  

Several factors can increase the risk of developing prostate cancer. Age is a significant risk factor, with the likelihood increasing as men get older. A family history of prostate cancer, particularly in a father or brother, also raises the risk. Race and ethnicity play a role, with African American men having a higher risk than men of other races. Diet and lifestyle factors are also being studied for their potential impact.  

Diagnosis of prostate cancer typically involves a digital rectal exam (DRE), where a doctor feels the prostate gland, and a prostate-specific antigen (PSA) blood test, which measures a protein produced by the prostate gland. Elevated PSA levels can indicate the presence of cancer, but further tests like a prostate biopsy are needed to confirm the diagnosis and determine the grade and stage of the cancer.  

Treatment options for prostate cancer vary depending on the stage of the cancer, the patient’s age and overall health, and

their preferences. Options can include active surveillance (closely monitoring the cancer), surgery to remove the prostate gland, radiation therapy, hormone therapy, chemotherapy, and targeted therapy. Early detection offers the best chance for successful treatment.  

Research Progress

.

The Open Science Institute’s Prostate Cancer Initiative has now progressed to the Systems Architecture phase — Publication.

We need your support to move forward. Our goal is to raise $2 Million to research and reveal to the scientific community, highlighting the powerful potential of Prostate Cancer. Please support this initiative.

Systems Architecture

The Systems Architecture of Prostate Cancer is published as a Web-based tool open to public. Click below to interact with the systems architecture

Publication

A peer-reviewed publication from the Prostate Cancer Research Initiative will be released soon to benefit the public by revealing powerful insights into the use of herbs for treating diseased conditions—support this initiative to advance scientific discovery and deliver real solutions through herbal medicine.

In silico Modeling

In this phase, the prostate cancer Initiative will conduct in silico modeling to identify and test the efficacy of ingredients on cell proliferation, angiogenesis and oncogenesis activity. This phase is yet to begin.

Combination Screening

Patents

The Open Science Institute® through its Prostate Cacner initiative is moving towards getting patents for a revolutionary compunds that affects cell proliferation, oncogenesis and angiogenesis

Licensing and Manufacturing

The Prostate Cancer Initiative plans to discover, develop, license and manufacture a prostate cancer product which supports treatment of prostate cancer. Support our mission to bring this innovation to those who need it most. Please support this Phase by donating to the Prostate Cancer Initiative